Antibodies directed against the il-18 beta receptor (il-18rβ) and related methods

CO20260010374A2Pending Publication Date: 2026-07-31BRISTOL MYERS SQUIBB CO

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: CO · CO
Patent Type: Applications
Current Assignee / Owner: BRISTOL MYERS SQUIBB CO
Filing Date: 2026-07-17
Publication Date: 2026-07-31

Application Information

Patent Timeline

17 Jul 2026

Application

31 Jul 2026

Publication

CO20260010374A2

IPC: C07K16/28; A61K39/00; A61P1/00

CPC: C07K16/2866; C07K2317/24; C07K2317/76; C07K2317/33; C07K2317/94; A61K2039/505; C07K2317/92; A61P1/00

Inventors: PACE Samantha Elaine; ZAMMIT David John

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Abstract

Novel antibodies and antigen-binding fragments thereof that bind to the interleukin-18 beta receptor (IL-18RP), along with conjugates thereof, nucleic acids encoding them, compositions comprising them, and methods for producing and using them, including for the treatment of various diseases and conditions such as inflammatory bowel disease and other immune-mediated diseases, autoimmune diseases, inflammatory diseases, cancers, and infectious diseases, are provided.

Need to check novelty before this filing date? Find Prior Art